Cargando…
High-dose methotrexate in ICU patients: a retrospective study
BACKGROUND: High-dose methotrexate (HD-MTX) is commonly used in the treatment of solid tumors and hematological malignancies. Severe toxicities are frequent, leading to organ dysfunction and death. Risk–benefit ratio of using HD-MTX in critically ill patients is unknown. This study aims to describe...
Autores principales: | Valade, Sandrine, Mariotte, Eric, Azoulay, Elie, Darmon, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293713/ https://www.ncbi.nlm.nih.gov/pubmed/32535662 http://dx.doi.org/10.1186/s13613-020-00693-5 |
Ejemplares similares
-
Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survival
por: Dupont, Thibault, et al.
Publicado: (2022) -
The use of ICU resources in CAR-T cell recipients: a hospital-wide study
por: Valade, Sandrine, et al.
Publicado: (2022) -
Clinical Warburg effect in lymphoma patients admitted to intensive care unit
por: Chaba, Anis, et al.
Publicado: (2023) -
Molecular detection of respiratory viruses in immunocopromised ICU patients: Incidence and meaning
por: Schnell, David, et al.
Publicado: (2012) -
Renal recovery after severe acute kidney injury in critically ill myeloma patients: a retrospective study
por: Joseph, Adrien, et al.
Publicado: (2018)